Sentence examples for total mean difference from inspiring English sources

The total mean difference between the processes was €32.5 (95%CI, -29.0 to 74.7).

Decrements exceeded the MCSD difference on the HADS total (mean difference 3.4, 95% CI 1.9 to 4.8) for the readmitted group.

In group 8-12, children of parents born in the Netherlands had a significantly lower total (mean difference = 3.94, p <.05), psychosocial (mean difference = 4.63, p <.01), emotional (mean difference = 5.39, p <.05) and school functioning score (mean difference = 4.31, p <.05) compared to children of parents born in another country.

Post hoc tests revealed that children of low educated parents scored higher than children of parents with a middle education on the total (mean difference = 6.21, p <.0167), psychosocial (mean difference = 7.69, p <.01), social (mean difference = 8.46, p <.01) and school subscale (mean difference = 8.99, p <.0167) of the PedsQL.

At six months, the total mean difference in change in total ADHD symptom scores between groups was −3.5 (−5.8 to −1.2; P=0.003), of which −1.2 (−2.1 to −0.3; P=0.01) was mediated through improved children's sleep habits questionnaire total score, and −2.3 (−4.7 to −0.003; P=0.05) was explained directly or through other pathways.

Mean costs of the teledermatological process per care episode were €387 (95%CI, 281 to 502.5) and mean conventional process costs were €354.0 (95%CI, 228.0 to 484.0), a total mean difference of €32.5 (95%CI, -29 to 74.7) (Table 2).

The CRP rate was significant higher at OOH than at daytime in the total material, mean difference from daytime to OOH 0.14 (CI 0.09-0.19, p < 0.001) (not tabled).

However, these differences in SRMs were not significant in either the total group (mean difference 0.08; 95% CI: -0.01 to 0.18) or the low disease activity group (mean difference 0.03; 95% CI: -0.08 to 0.15).

We similarly selected 2639 genes (upper 10% of total genes) (mean difference of tag counts by MACS<−3) showing lower hmC density at the TSS±1 k bp regions in lymphoma cells compared with the control CD4+ cells, in light of a recent report demonstrating that hmC at the promoter region negatively regulates gene expression.

A cost-effectiveness analysis will be conducted comparing the difference in total mean costs to the difference in effects on BPs; a cost-utility analysis will estimate the incremental costs per QALY.

A cost-effectiveness (CE) analysis will be performed comparing the difference in total mean costs to the difference in quality of life, functional status and care needs; a cost-utility (CU) analysis will be used to estimate the incremental costs per QALY.